logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9351972 B1

PDFFull Text
Date of Patent:
May. 31, 2016

Filed:

Nov. 29, 2011

Compounds as respiratory stimulants for treatment of breathing control disorders or diseases

Applicants:

Scott L. Dax, Landenberg, PA (US);

Richard Woodward, Phoenixville, PA (US);

Sean Peng, Ambler, PA (US);

Inventors:

Scott L. Dax, Landenberg, PA (US);

Richard Woodward, Phoenixville, PA (US);

Sean Peng, Ambler, PA (US);

Assignee:

Galleon Pharmaceuticals, Inc., Doylestown, PA (US);

Attorneys:

Saul Ewing LLP

Kathryn Doyle

Domingos J. Silva

Primary Examiner:

Timothy Thomas

Int. Cl.
CPC ...
C07D 251/70 (2006.01); C07D 403/12 (2006.01); C07D 401/12 (2006.01); C07D 405/14 (2006.01); C07D 409/12 (2006.01); C07D 498/08 (2006.01); C07D 413/04 (2006.01); A61K 31/505 (2006.01); A61K 31/519 (2006.01); A61K 31/522 (2006.01); A61K 31/53 (2006.01); A61K 31/5355 (2006.01); A61K 31/57 (2006.01); A61K 45/06 (2006.01); C07D 251/66 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01); C07D 487/04 (2006.01); C07D 498/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/505 (2013.01); A61K 31/519 (2013.01); A61K 31/522 (2013.01); A61K 31/53 (2013.01); A61K 31/5355 (2013.01); A61K 31/57 (2013.01); A61K 45/06 (2013.01); C07D 251/66 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 413/04 (2013.01); C07D 487/04 (2013.01); C07D 498/06 (2013.01);
Abstract

The present invention includes a composition comprising a compound, such as a 2,4,6-triamino-1,3,5-triazine, 2,4,6-triaminopyrimidine, 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine or 2,4-diamino-7H-pyrrolo[2,3-d]pyrimidine, that is useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition of the invention. The present invention further includes a method of preventing destabilizing or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition of the invention.

Find Patent Forward Citations

Loading…